IFNA1 and systemic sclerosis: This is supported by studies showing that a subgroup of SSc patients displays activation of type I interferons (IFN), key regulators of the innate immune system in SSc patients [11–14], and an increased number of macrophages and monocytes in the blood and in the skin compared to healthy individuals [7, 15].